Bristol-Myers Squibb Company (BVMF:BMYB34)

Brazil flag Brazil · Delayed Price · Currency is BRL
300.60
0.00 (0.00%)
Last updated: Jan 14, 2026, 10:00 AM GMT-3
-13.67%
Market Cap618.83B
Revenue (ttm)255.99B
Net Income (ttm)32.18B
Shares Outn/a
EPS (ttm)15.83
PE Ratio19.23
Forward PE9.19
Dividend9.06 (3.02%)
Ex-Dividend DateJan 2, 2026
Volumen/a
Average Volume46
Open300.60
Previous Close300.60
Day's Range300.60 - 300.60
52-Week Range227.85 - 369.03
Beta0.30
RSI71.16
Earnings DateFeb 5, 2026

About BVMF:BMYB34

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange Brazil Stock Exchange
Ticker Symbol BMYB34
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.